S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
S&P 500   2,629.14 (+5.65%)
DOW   22,295.53 (+5.90%)
QQQ   193.92 (+5.75%)
AAPL   255.39 (+5.79%)
FB   163.68 (+6.16%)
MSFT   161.90 (+5.25%)
GOOGL   1,167.42 (+6.84%)
CGC   14.28 (+7.77%)
MU   45.55 (+10.50%)
GE   7.17 (+5.91%)
TSLA   507.13 (+5.65%)
AMD   46.30 (+8.71%)
T   29.17 (+5.92%)
F   4.49 (+5.90%)
NFLX   374.79 (+3.53%)
GILD   76.11 (-2.68%)
DIS   98.00 (+4.33%)
PRI   86.74 (+7.50%)
Log in

TSE:EDTSpectral Medical Stock Price, Forecast & News

C$0.51
+0.01 (+2.00 %)
(As of 04/6/2020 02:47 PM ET)
Add
Compare
Today's Range
C$0.51
Now: C$0.51
C$0.52
50-Day Range
C$0.41
MA: C$0.58
C$0.75
52-Week Range
C$0.30
Now: C$0.51
C$0.85
Volume4,000 shs
Average Volume84,559 shs
Market CapitalizationC$115.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan. It also develops, produces, and markets recombinant proteins, antibodies, and calibrators for use in the research and development, as well as markets products that are manufactured by other diagnostic companies; and develops continuous renal replacement therapy, an open platform for other hemoperfusion cartridges. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.08 out of 5 stars


Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-416-6263233

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.87 million
Cash FlowC$0.01 per share
Book ValueC$0.01 per share

Profitability

Miscellaneous

Employees18
Market CapC$115.17 million
Next Earnings Date5/14/2020 (Estimated)
OptionableNot Optionable

Receive EDT News and Ratings via Email

Sign-up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.


Spectral Medical (TSE:EDT) Frequently Asked Questions

How has Spectral Medical's stock been impacted by COVID-19 (Coronavirus)?

Spectral Medical's stock was trading at C$0.57 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, EDT shares have decreased by 10.5% and is now trading at C$0.51. View which stocks have been mosted impacted by Coronavirus.

When is Spectral Medical's next earnings date?

Spectral Medical is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Spectral Medical.

Has Spectral Medical been receiving favorable news coverage?

News stories about EDT stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Spectral Medical earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutSpectral Medical.

Who are some of Spectral Medical's key competitors?

Some companies that are related to Spectral Medical include VolitionRX (VNRX), ANGLE (AGL), Proteome Sciences (PRM), DiaSorin (DIA), Polarityte (COOL) and Premaitha Health (NIPT).

What other stocks do shareholders of Spectral Medical own?

Who are Spectral Medical's key executives?

Spectral Medical's management team includes the following people:
  • Dr. Paul M. Walker, Pres, CEO & Director (Age 70)
  • Dr. Gualtiero Guadagni, VP of Sales & Marketing
  • Mr. Richard Wieland, Interim Chief Financial Officer

What is Spectral Medical's stock symbol?

Spectral Medical trades on the Toronto Stock Exchange (TSX) under the ticker symbol "EDT."

How do I buy shares of Spectral Medical?

Shares of EDT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Spectral Medical's stock price today?

One share of EDT stock can currently be purchased for approximately C$0.51.

How big of a company is Spectral Medical?

Spectral Medical has a market capitalization of C$115.17 million and generates C$2.87 million in revenue each year. Spectral Medical employs 18 workers across the globe. View additional information about Spectral Medical.

What is Spectral Medical's official website?

The official website for Spectral Medical is http://www.spectraldx.com/.

How can I contact Spectral Medical?

Spectral Medical's mailing address is 135 the West Mall Unit 2, ETOBICOKE, ON M9C 1C2, Canada. The company can be reached via phone at +1-416-6263233.

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel